Salud

Novo Nordisk is lifting prescription restrictions on its weight-loss drug Wegovy in the United States and increasing shipments to that market, its chief executive said

Novartis CEO Vas Narasimhan said in an interview on Saturday that he expects to increase its annual sales by at least 5 per cent a

Novo Nordisk said Friday that its weight-loss drug achieved the primary goal of a late-stage study in patients with fatty liver disease, reducing scarring of

EU competition authorities will decide by 6 December whether to approve Novo Holdings’ acquisition of contract drugmaker Catalent, the European Commission said in a document

The U.S. Food and Drug Administration on Friday warned against the use of compounded drugs, including versions of popular weight-loss products made at a California

Novo Nordisk said Friday that its weight-loss drug achieved the primary goal of a late-stage study in patients with fatty liver disease, reducing scarring of

Novartis CEO Vas Narasimhan said in an interview on Saturday that he expects to increase its annual sales by at least 5 per cent a

Starting a more gradual dosing schedule for Eli Lilly’s Alzheimer’s disease drug Kisunla reduces the percentage of patients suffering from potentially serious brain swelling, according

GSK on Wednesday said sales of its vaccines would fall this year after weaker-than-expected sales results for respiratory syncytial virus (RSV) and shingles vaccines in

Tuberculosis has replaced COVID-19 to become the leading cause of death from infectious diseases in 2023, according to a World Health Organisation report released Tuesday